A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)

Rees, K. E., Chyou, T. yuan, & Nishtala, P. S. (2020, June 1). A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS). Drug Safety. Adis. https://doi.org/10.1007/s40264-020-00928-1